This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Elsje C. Barendswaard
Introduction
Elsje C. Barendswaard is a notable inventor based in New York, NY (US). She has made significant contributions to the field of cancer research, particularly in the development of monoclonal antibodies. Her work is vital for advancing diagnostic and therapeutic techniques in oncology.
Latest Patents
Elsje holds a patent for hybridoma cell lines that produce monoclonal antibodies. Specifically, her monoclonal antibody, designated as 100-310, has been found to be reactive against colon cancer cells. This innovation is particularly useful for diagnostic imaging and treatment of colon cancer, showcasing her commitment to improving patient outcomes.
Career Highlights
Elsje is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer treatment and research. Her role at this prestigious center allows her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Sydney Welt and Clarence Williams, Jr. Their collective expertise enhances the research environment and fosters innovation in cancer therapies.
Conclusion
Elsje C. Barendswaard's contributions to cancer research through her patent and work at Memorial Sloan Kettering Cancer Center highlight her as a key figure in the fight against colon cancer. Her innovative spirit and dedication to improving healthcare are commendable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile